Central Line-Associated Bloodstream Infection QI Project

Central Line-Associated Bloodstream Infection (CLABSI) Quality Improvement Project

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07746674

Acronym

CLABSI

Enrollment

Registered

2026-08-05

Start date

2026-09-01

Completion date

2027-03-01

Last updated

2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central Line-associated Bloodstream Infection (CLABSI)

Brief summary

This study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to document line necessity. The study compares alert and a secure chat intervention to usual care, with the goal of reducing unnecessary line days and related CLABSI risk.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Not hospice patient class * Active central line for at least 24 hours

Exclusion criteria

* No active central line * Central line present for less than 24 hours

Design outcomes

Primary

Measure	Time frame
Total number of central line days without a documented indication	Up to Month 3

Secondary

Measure	Time frame
Number of femoral central lines in place for more than 2 days	Up to Month 3
Number of non-tunneled hemodialysis catheters without an active hemodialysis or continuous renal replacement therapy order	Up to Month 3

Countries

United States

Contacts

CONTACTSarah Tsuruo

Sarah.Tsuruo@nyulangone.org914-815-4079

CONTACTHolly Krelle

Holly.Krelle@nyulangone.org347-200-1108

PRINCIPAL_INVESTIGATORHolly Krelle

NYU Langone Health

Outcome results